MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer

Establishment of a Korea HPV cohort study

(2013) Won-Chul Lee et al.   Journal of Gynecologic Oncology

ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients

(2010) Roger W. McGilvray et al.   INTERNATIONAL JOURNAL OF CANCER

NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting

(2009) R. W. McGilvray et al.   CLINICAL CANCER RESEARCH

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

(2008) Kui Li et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer

(2008) Sonja Textor et al.   INTERNATIONAL JOURNAL OF CANCER

Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D

(2008) Noam Stern-Ginossar et al.   NATURE IMMUNOLOGY